SAM
CODX

Strategic Asset Management’s Co-Diagnostics CODX Stock Holding History

Strategic Asset Management’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$3K Hold
33
– – 0.01% 514
2022
Q2 		$6K Buy
+33
New +$5.02K 0.01% 457

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Strategic Asset Management's CODX Position: Q3 2022 in Review

Strategic Asset Management held its Co-Diagnostics (CODX) position steady in Q3 2022 at 33 shares worth $3K. The position accounts for 0.01% of the portfolio, ranked #514.

Strategic Asset Management first reported a position in CODX in Q2 2022 and has held it in 2 quarters since. The position peaked at $6K in Q2 2022. 65 funds tracked by Wall St. Rank hold CODX as of Q3 2022.

  • Strategic Asset Management held 33 shares of Co-Diagnostics worth $3K as of Q3 2022.
  • Strategic Asset Management left its Co-Diagnostics share count unchanged in Q3 2022.
  • Co-Diagnostics made up 0.01% of Strategic Asset Management's portfolio in Q3 2022, its #514 holding.
  • Strategic Asset Management first reported a position in Co-Diagnostics in Q2 2022 and has held it in 2 quarters since.
  • Strategic Asset Management's Co-Diagnostics position peaked at $6K in Q2 2022.
  • 65 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2022.

Based on Strategic Asset Management's 13F filing for Q3 2022, filed 1 Nov 2022.